PCG
VNDA icon

Private Capital Group’s Vanda Pharmaceuticals VNDA Stock Holding History

Private Capital Group’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-27
Closed – – 2146
2019
Q4 		$0 Hold
27
– – ﹤0.01% 2198
2019
Q3 		$0 Buy
+27
New +$376 ﹤0.01% 2459
2019
Q2 		– Sell
-27
Closed – – 2429
2019
Q1 		$0 Hold
27
– – ﹤0.01% 2320
2018
Q4 		$1K Buy
+27
New +$635 ﹤0.01% 2114

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Private Capital Group's VNDA Position: Q1 2020 in Review

Private Capital Group sold out of Vanda Pharmaceuticals (VNDA) in Q1 2020, closing a stake of 27 shares.

Private Capital Group first reported a position in VNDA in Q4 2018 and held it in 4 quarters. The position peaked at $1K in Q4 2018. 159 funds tracked by Wall St. Rank hold VNDA as of Q1 2020.

  • Private Capital Group reported no remaining Vanda Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Private Capital Group sold 27 Vanda Pharmaceuticals shares in Q1 2020.
  • Private Capital Group first reported a position in Vanda Pharmaceuticals in Q4 2018 and held it in 4 quarters.
  • Private Capital Group's Vanda Pharmaceuticals position peaked at $1K in Q4 2018.
  • 159 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2020.

Based on Private Capital Group's 13F filing for Q1 2020, filed 7 May 2020.